Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cogent

50.25
-0.2000-0.40%
Post-market: 50.250.00000.00%16:33 EDT
Volume:418.94K
Turnover:21.01M
Market Cap:2.48B
PE:-12.56
High:50.81
Open:50.65
Low:49.65
Close:50.45
Loading ...

Dave Schaeffer, Chairman, CEO, and President, Reports Disposal of Common Shares of Cogent Communications Holdings Inc

Reuters
·
15 May

Director Sheryl Lynn Kennedy Reports Disposal of Common Shares in Cogent Communications Holdings Inc

Reuters
·
14 May

Cogent Comms Faces Financial Strain Amid Weak Performance and Delayed Asset Monetization

TIPRANKS
·
12 May

Cogent Communications Is Maintained at Neutral by Goldman Sachs

Dow Jones
·
10 May

UBS Adjusts Price Target on Cogent Communications to $75 From $102, Maintains Buy Rating

MT Newswires Live
·
09 May

Cogent price target lowered to $75 from $102 at UBS

TIPRANKS
·
09 May

Cogent Comms: Strategic Adjustments and Growth Potential Present a Buying Opportunity

TIPRANKS
·
09 May

Cogent Comms Annual Meeting Decisions Impact Governance

TIPRANKS
·
09 May

Stock Track | Cogent Communications Plummets 7.40% as Q1 Earnings Miss Estimates, Despite Dividend Increase

Stock Track
·
08 May

Cogent Communications Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Cogent Communications' Q1 Loss Narrows, Revenue Rises

MT Newswires Live
·
08 May

Stock Track | Cogent Communications Plunges 5.28% Pre-market on Q1 Earnings Miss

Stock Track
·
08 May

Earnings Flash (CCOI) Cogent Communications Holdings Posts Q1 Loss $1.09 a Share, vs. FactSet Est of $1.06 Loss

MT Newswires Live
·
08 May

Cogent Comms Hldgs Q1 EPS $(1.09) Misses $(1.05) Estimate, Sales $247.05M Miss $250.97M Estimate

Benzinga
·
08 May

BRIEF-Cogent Communications Q1 Basic EPS USD -1.09

Reuters
·
08 May

Cogent Communications Q1 Gross Profit USD 33.571 Million

THOMSON REUTERS
·
08 May

Cogent Communications Reports First Quarter Results and Increases Its Regular Quarterly Dividend on Its Common Stock

THOMSON REUTERS
·
08 May

Cogent Biosciences Is Maintained at Neutral by Baird

Dow Jones
·
08 May

Wedbush Trims Price Target on Cogent Biosciences to $10 From $11, Maintains Neutral Rating

MT Newswires Live
·
06 May

Cogent Biosciences Q1 EPS $(0.52) Beats $(0.61) Estimate

Benzinga
·
06 May